Bahl & Gaynor’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-11,511
Closed -$408K 451
2015
Q1
$408K Buy
11,511
+430
+4% +$15.2K 0.01% 331
2014
Q4
$377K Buy
11,081
+240
+2% +$8.17K 0.01% 330
2014
Q3
$418K Buy
10,841
+1,330
+14% +$51.3K 0.01% 308
2014
Q2
$370K Buy
9,511
+150
+2% +$5.84K 0.01% 313
2014
Q1
$320K Buy
+9,361
New +$320K 0.01% 329